cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0003209,C0439662,AFFECTS,Anti-Inflammatory Agents,Immune,phsu,ftcn,1,AFFECTS_PHSUafctFTCN
C0014695,C0439662,AFFECTS,Ergocalciferol,Immune,phsu,ftcn,1,AFFECTS_PHSUafctFTCN
C0032414,C0439662,AFFECTS,Poly I-C,Immune,phsu,ftcn,1,AFFECTS_PHSUafctFTCN
C0050063,C0205161,AFFECTS,8-chloro-cyclic adenosine monophosphate,Abnormal,phsu,ftcn,1,AFFECTS_PHSUafctFTCN
C0133819,C0439662,AFFECTS,oligoadenylate,Immune,phsu,ftcn,1,AFFECTS_PHSUafctFTCN
C1718097,C0439662,AFFECTS,New medications,Immune,phsu,ftcn,1,AFFECTS_PHSUafctFTCN
